Search Results - "de Mattos, Angelo"

Refine Results
  1. 1

    Albumin in the management of hepatic encephalopathy: A systematic review and meta-analysis by Bombassaro, Isadora Z., Tovo, Cristiane V., de Mattos, Ângelo Z., Ahlert, Marcelo, Chiesa, Talita, de Mattos, Angelo A.

    Published in Annals of hepatology (01-12-2021)
    “…Introduction and objectives It has been suggested that albumin administration could alter the natural history of cirrhosis, and also, that long‐term treatment…”
    Get full text
    Journal Article
  2. 2

    Long‐term albumin administration in patients with cirrhosis and ascites: A meta‐analysis of randomized controlled trials by Sandi, Bianca Boff, Leão, Gabriel Stefani, Mattos, Angelo Alves, Mattos, Ângelo Zambam

    Published in Journal of gastroenterology and hepatology (01-03-2021)
    “…Background and Aim Ascites is a common complication of cirrhosis, and it is associated with increased mortality. The aim of this study was to evaluate the…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Acute-on-chronic liver failure: A comparison of three different diagnostic criteria by Leão, Gabriel S, Lunardi, Felipe L, Picon, Rafael V, Tovo, Cristiane V, de Mattos, Angelo A, de Mattos, Ângelo Z

    Published in Annals of hepatology (01-03-2019)
    “…AbstractIntroduction and aimDifferent criteria are applied for the diagnosis of acute-on-chronic liver failure (ACLF). Our aim was to compare the performance…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Albumin for cirrhotic patients with extraperitoneal infections: A meta‐analysis by Leão, Gabriel Stefani, John Neto, Guilherme, Jotz, Raquel de Freitas, Mattos, Angelo Alves de, Mattos, Ângelo Zambam de

    Published in Journal of gastroenterology and hepatology (01-12-2019)
    “…Background and Aim Bacterial infections are among the main causes of death in patients with cirrhosis. While there are unquestionable benefits of using albumin…”
    Get full text
    Journal Article
  7. 7

    Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis by Tovo, Cristiane Valle, de Mattos, Angelo Zambam, Coral, Gabriela Perdomo, Sartori, Giovana D P, Nogueira, Livia Villela, Both, Gustavo Tovo, Villela-Nogueira, Cristiane A, de Mattos, Angelo A

    Published in World journal of gastroenterology : WJG (14-01-2023)
    “…Cirrhosis is an emerging major cause of the development of hepatocellular carcinoma (HCC), but in non-alcoholic fatty liver disease (NAFLD), up to 50% of…”
    Get full text
    Journal Article
  8. 8

    Albumin administration in patients with cirrhosis: Current role and novel perspectives by de Mattos, Ângelo Zambam, Simonetto, Douglas Alano, Terra, Carlos, Farias, Alberto Queiroz, Bittencourt, Paulo Lisboa, Pase, Tales Henrique Soares, Toazza, Marlon Rubini, de Mattos, Angelo Alves

    Published in World journal of gastroenterology : WJG (07-09-2022)
    “…Mortality in cirrhosis is mostly associated with the development of clinical decompensation, characterized by ascites, hepatic encephalopathy, variceal…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12

    THE ROLE OF ELASTOGRAPHY IN CLINICALLY SIGNIFICANT PORTAL HYPERTENSION by MATTOS, Angelo Alves de, MATTOS, Angelo Zambam de, SARTORI, Giovana Dal Pozzo, BOTH, Gustavo Tovo, TOVO, Cristiane Valle

    Published in Arquivos de gastroenterologia (01-11-2023)
    “…ABSTRACT This is a narrative review that aims to discuss the importance of elastographic methods in the evaluation of clinically significant portal…”
    Get full text
    Journal Article
  13. 13

    Current impact of viral hepatitis on liver cancer development: The challenge remains by de Mattos, Ângelo Zambam, Debes, Jose D, Boonstra, Andre, Yang, Ju-Dong, Balderramo, Domingo C, Sartori, Giovana D P, de Mattos, Angelo Alves

    Published in World journal of gastroenterology : WJG (28-06-2021)
    “…Chronic infections due to hepatitis B and hepatitis C viruses are responsible for most cases of hepatocellular carcinoma (HCC) worldwide, and this association…”
    Get full text
    Journal Article
  14. 14

    Hepatorenal syndrome: Current concepts related to diagnosis and management by de Mattos, Ângelo Zambam, de Mattos, Angelo Alves, Méndez-Sánchez, Nahum

    Published in Annals of hepatology (01-07-2016)
    “…AbstractRenal failure in cirrhotic patients is a very severe condition. Hepatorenal syndrome has the worst prognosis among all causes of kidney failure in such…”
    Get full text
    Journal Article
  15. 15

    PERFORMACE OF TRIGLYCERIDE-GLUCOSE INDEX ON DIAGNOSIS AND STAGING OF NAFLD IN OBESE PATIENTS by SMIDERLE, Carla Alessandra, CORAL, Gabriela Perdomo, DE CARLI, Luiz Alberto, MATTOS, Angelo Alves de, MATTOS, Angelo Zambam de, TOVO, Cristiane Valle

    Published in Arquivos de gastroenterologia (01-06-2021)
    “…ABSTRACT BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is the most prevalent liver disease in the world, and its prevalence is increasing alongside…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    Treatment of hepatocellular carcinoma using transarterial chemoembolization: a real-life, single-centre study from Southern Brazil by Lionço, Lívia C, de Mattos, Angelo A, Horbe, Alex F, Costabeber, Ane M, de Mattos, Ângelo Z, Tarasconi, Dorvaldo P

    “…OBJECTIVEThe main aim of this study was to evaluate the real-life survival rates of patients with intermediate-stage hepatocellular carcinoma treated with…”
    Get full text
    Journal Article